Macitentan as a repurposed MCL-1 inhibitor in triple-negative breast cancer: Insights from molecular docking, MM-GBSA, and MD simulations.
Saved in:
| Title: | Macitentan as a repurposed MCL-1 inhibitor in triple-negative breast cancer: Insights from molecular docking, MM-GBSA, and MD simulations. |
|---|---|
| Authors: | Fadlalla, Abdalla (AUTHOR), Makki, Alaa A. (AUTHOR), Ibraheem, Walaa (AUTHOR), Abdelrhman, Mohammed (AUTHOR), Alzain, Abdulrahim A. (AUTHOR), Ashour, Ahmed (AUTHOR) ahmedadelashour@yahoo.com%20, Osman, Wadah (AUTHOR), Alqarni, Mohammed Hamed (AUTHOR), Foudah, Ahmed I. (AUTHOR), El-Sakhawy, Mohamed A. (AUTHOR) |
| Source: | Journal of King Saud University - Science. May2026, Vol. 38 Issue 5, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10183647 |
|---|---|
| DOI: | 10.25259/JKSUS_1725_2025 |
